Immucell Stock Market Value
| ICCC Stock | USD 3.70 0.04 1.07% |
| Symbol | ImmuCell |
ImmuCell Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmuCell. If investors know ImmuCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmuCell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (0.49) | Revenue Per Share 2.991 | Quarterly Revenue Growth 0.549 | Return On Assets (0.05) |
The market value of ImmuCell is measured differently than its book value, which is the value of ImmuCell that is recorded on the company's balance sheet. Investors also form their own opinion of ImmuCell's value that differs from its market value or its book value, called intrinsic value, which is ImmuCell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmuCell's market value can be influenced by many factors that don't directly affect ImmuCell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmuCell's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmuCell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmuCell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ImmuCell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmuCell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmuCell.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in ImmuCell on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding ImmuCell or generate 0.0% return on investment in ImmuCell over 720 days. ImmuCell is related to or competes with Transgene, Alpha Cognition, Fennec Pharmaceuticals, Lipella Pharmaceuticals, Eliem Therapeutics, Anebulo Pharmaceuticals, and HCW Biologics. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and... More
ImmuCell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmuCell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmuCell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.59 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 21.64 | |||
| Value At Risk | (3.29) | |||
| Potential Upside | 3.4 |
ImmuCell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmuCell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmuCell's standard deviation. In reality, there are many statistical measures that can use ImmuCell historical prices to predict the future ImmuCell's volatility.| Risk Adjusted Performance | 0.024 | |||
| Jensen Alpha | 0.1314 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | (0.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmuCell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ImmuCell Backtested Returns
ImmuCell holds Efficiency (Sharpe) Ratio of -0.0158, which attests that the entity had a -0.0158% return per unit of risk over the last 3 months. ImmuCell exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ImmuCell's Risk Adjusted Performance of 0.024, market risk adjusted performance of (0.06), and Downside Deviation of 2.59 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.7, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ImmuCell are expected to decrease at a much lower rate. During the bear market, ImmuCell is likely to outperform the market. At this point, ImmuCell has a negative expected return of -0.0294%. Please make sure to check out ImmuCell's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to decide if ImmuCell performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
ImmuCell has average predictability. Overlapping area represents the amount of predictability between ImmuCell time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmuCell price movement. The serial correlation of 0.46 indicates that about 46.0% of current ImmuCell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
ImmuCell lagged returns against current returns
Autocorrelation, which is ImmuCell stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImmuCell's stock expected returns. We can calculate the autocorrelation of ImmuCell returns to help us make a trade decision. For example, suppose you find that ImmuCell has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ImmuCell regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImmuCell stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImmuCell stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImmuCell stock over time.
Current vs Lagged Prices |
| Timeline |
ImmuCell Lagged Returns
When evaluating ImmuCell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImmuCell stock have on its future price. ImmuCell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImmuCell autocorrelation shows the relationship between ImmuCell stock current value and its past values and can show if there is a momentum factor associated with investing in ImmuCell.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImmuCell offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImmuCell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immucell Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immucell Stock:Check out ImmuCell Correlation, ImmuCell Volatility and ImmuCell Alpha and Beta module to complement your research on ImmuCell. For information on how to trade ImmuCell Stock refer to our How to Trade ImmuCell Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
ImmuCell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.